Читать книгу Mutagenic Impurities - Группа авторов - Страница 57

In the context of changes to the DP, such as a modified formulation, the guideline makes clear that the focus is specifically on the DP and on any new or increased levels of a mutagenic degradant arising as a result of that change. Critically, it makes clear that changes to the formulated product do not trigger a reevaluation of the route of synthesis of the DS, unless there is a concomitant change.